Neurons may live for decades with neurofibrillary tangles

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 2, 1999, Pages 188-197

  Morsch, Renee ^a   Simon, William ^a   Coleman, Paul D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Neurofibrillary tangles; Neuron death

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; MODEL; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0033028074     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199902000-00008     Document Type: Article

References (38)

1. The National Institute on Aging and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18:S1-S2
2. West MJ, Coleman PD, Flood DG, Troncosco JC. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 1994;344:769-72
3. Morris JC, McKeel DW, Storandt M, et al. Very mild Alzheimer's disease: Informant based clinical, psychometric, and pathological distinction from normal aging. Neurology 1991;41:469-78
4. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988;38:1682-87
5. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992b;42;1681-88
6. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-57
7. Griffin WS, Ling C, White CL, Morrison-Bogorad M. Polyadenylated messenger RNA in paired helical filament-immunoreatcive neurons in Alzheimer disease. Alzheimer Dis Assoc Disord. 1990; 4:69-78
8. Doebler JA, Markesbery WR, Anthony A, Davies P, Scheff SW, Rhoads RE. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease. Ann Neurol. 1988;23:20-24
9. Callahan LM, Selski DJ, Martzen MR, Cheetham JE, Coleman PD. Preliminary evidence: Decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus. Neurobiol Aging 1994;15:381-86
10. Callahan LM, Coleman PD. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 1995;16:311-14
11. Bobinski M, Wegiel J, Tarnawski M, et al. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropath Exp Neurol 1997;56:414-20
12. West MJ. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 1993;14:287-93
13. Yamamoto T, Hirano A. A comparative study of Modified Bielschowsky, Bodian, and Thioflavin S stains on Alzheimer's neurofibrillary tangles J Neuropath Appl Neurobiol 1986; 12: No.3-9
14. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992;14:59-82
15. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neurosci 1995;64:209-17
16. Gomez-Isla T, Price JL, McKeel DW. Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-5000
17. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24
18. Regeur L, Jenscn GB, Pakkenberg H, Evans SM, Pakkenberg B. No global neocortical nerve-cell loss in brains from patients with senile dementia of the Alzheimer's type. Neurobiology of Aging 1994;15:347-52
19. Bobinski M, Wegiel J, Tarnawski M, et al. Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res (In Press)
20. Kenessey A, Yen SH, Liu WK, Yang XR, Dunlop DS. Detection of D-aspartate in tau proteins associated with Alzheimer paired helical filaments. Br Res 1995;675:183-89
21. Bada JL. Racemization of amino acids. In: G.C. Barrett, ed. Chemistry and Biochemistry of the Amino Acids. New York: Chapman and Hall, 1985;399-414
22. Grignon Y, Duyekaerts C, Bennecib M, Hauw JJ. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol 1998;95:395-406
23. Sheng JG, Mrak RE, Griffin WST. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:323-28
24. Hatanpaa K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996;40:411-20
25. Chow N, Cox C. Callahan LM, Weimer JM, Guo L, Coleman PD. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc Natl Acad Sci USA (In Press)
26. McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Amer J Pathol 1997;150:1933-39
27. Nagy Z, Esiri MM, Cato AM, Smith AD. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 1997;94:6-15
28. Liu WK, Williams RT, Hall FL, Dickson DW, Yen SH. Detection of a CDC2-related kinase associated with Alzheimer's paired helical filament. Amer J Pathol 1995;146:228-38
29. Estus S, Tucker HM, vanRooyen C, et al. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction. J Neurosci 1997;17:7736-45
30. Li YP, Bushnell AF, Lee CM, Perlmutter LS, Wong SK. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 1996;738:196-204
31. Forloni G, Chiesa R, Smiroldo S, et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport 1993;4:523-26
32. Gschwind M, Huber G. Apoptotic cell death induced by beta-amyloid (1-42) peptide is cell type dependent. J Neurochem 1995;65: 292-300
33. Anderson AJ, Pike CJ, Cotman CW. Differential induction of immediate early gene proteins in cultured neurons by beta-amyloid (A-beta): association of c-jun with A-beta induced apoptosis. J Neurochem 1995;1487-98
34. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci USA 1994;91:7104-8
35. Greenberg SM, Qiu WQ, Selkoe DJ, Benitzhak A. Kosik KS. Amino-terminal region of the beta-amyloid precursor protein activates mitogen-activated protein kinase. Neurosci Lett 1995a:198:52-56
36. Greenberg SM, Kosik KS. Secreted beta-APP stimulates MAP kinase and phosphorylation of tau in neurons. Neurobiol Aging 1995b;16:403-7
37. Ferreira A, Lu Q, Orecchio L, Kosik KS. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci 1997;9:220-34
38. Bucigilio J, Lorenzo A, Yeh J, Yankner B. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995;14:879-88